Literature DB >> 26000477

Alike but Different: RAF Paralogs and Their Signaling Outputs.

Enrico Desideri1, Anna Lina Cavallo1, Manuela Baccarini2.   

Abstract

RAF links RAS, one of the most potent human oncogenes, to its effector ERK and to proliferation. This role is evolutionarily conserved, but while simpler multicellular organisms express one RAF, mammals have three. This Minireview highlights common and divergent features of RAF paralogs, their signaling outputs, and roles in tumorigenesis.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26000477     DOI: 10.1016/j.cell.2015.04.045

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  38 in total

Review 1.  NRAS mutant melanoma: an overview for the clinician for melanoma management.

Authors:  Russell W Jenkins; Ryan J Sullivan
Journal:  Melanoma Manag       Date:  2016-02-17

2.  B-Raf activation loop phosphorylation revisited.

Authors:  Martin Köhler; Tilman Brummer
Journal:  Cell Cycle       Date:  2016-04-21       Impact factor: 4.534

3.  MEK drives BRAF activation through allosteric control of KSR proteins.

Authors:  Hugo Lavoie; Malha Sahmi; Pierre Maisonneuve; Sara A Marullo; Neroshan Thevakumaran; Ting Jin; Igor Kurinov; Frank Sicheri; Marc Therrien
Journal:  Nature       Date:  2018-02-12       Impact factor: 49.962

4.  RAF1 amplification drives a subset of bladder tumors and confers sensitivity to MAPK-directed therapeutics.

Authors:  Raie T Bekele; Amruta S Samant; Amin H Nassar; Jonathan So; Elizabeth P Garcia; Catherine R Curran; Justin H Hwang; David L Mayhew; Anwesha Nag; Aaron R Thorner; Judit Börcsök; Zsofia Sztupinszki; Chong-Xian Pan; Joaquim Bellmunt; David J Kwiatkowski; Guru P Sonpavde; Eliezer M Van Allen; Kent W Mouw
Journal:  J Clin Invest       Date:  2021-11-15       Impact factor: 19.456

5.  Clinicopathologic and Molecular Characterization of Epstein-Barr Virus-positive Plasmacytoma.

Authors:  Ting Zhou; Jinjun Cheng; Jeremiah Karrs; Theresa Davies-Hill; Svetlana D Pack; Liqiang Xi; Manoj Tyagi; Jung Kim; Elaine S Jaffe; Mark Raffeld; Stefania Pittaluga
Journal:  Am J Surg Pathol       Date:  2022-06-01       Impact factor: 6.298

Review 6.  Two is better than one; toward a rational design of combinatorial therapy.

Authors:  Sheng-Hong Chen; Galit Lahav
Journal:  Curr Opin Struct Biol       Date:  2016-08-10       Impact factor: 6.809

7.  The road to ERK activation: Do neurons take alternate routes?

Authors:  Nadiatou Miningou; Kim T Blackwell
Journal:  Cell Signal       Date:  2020-01-13       Impact factor: 4.315

Review 8.  MYC and RAF: Key Effectors in Cellular Signaling and Major Drivers in Human Cancer.

Authors:  Eduard Stefan; Klaus Bister
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

9.  A comprehensive analysis of RAS-effector interactions reveals interaction hotspots and new binding partners.

Authors:  Soheila Rezaei Adariani; Neda S Kazemein Jasemi; Farhad Bazgir; Christoph Wittich; Ehsan Amin; Claus A M Seidel; Radovan Dvorsky; Mohammad R Ahmadian
Journal:  J Biol Chem       Date:  2021-04-27       Impact factor: 5.157

10.  Impairment of the neurotrophic signaling hub B-Raf contributes to motoneuron degeneration in spinal muscular atrophy.

Authors:  Niko Hensel; Federica Cieri; Pamela Santonicola; Ines Tapken; Tobias Schüning; Michela Taiana; Elisa Pagliari; Antonia Joseph; Silke Fischer; Natascha Heidrich; Hella Brinkmann; Sabrina Kubinski; Anke K Bergmann; Manuela F Richter; Klaus Jung; Stefania Corti; Elia Di Schiavi; Peter Claus
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.